Found: 128
Select item for more details and to access through your institution.
PSA doubling time 4.65 months as an optimal cut-off of Japanese nonmetastatic castration-resistant prostate cancer.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-65969-3
- By:
- Publication type:
- Article
Survival beyond cabazitaxel for metastatic castration‐resistant prostate cancer.
- Published in:
- International Journal of Urology, 2024, v. 31, n. 7, p. 829, doi. 10.1111/iju.15449
- By:
- Publication type:
- Article
Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 6, p. 3872, doi. 10.1245/s10434-024-14999-2
- By:
- Publication type:
- Article
ASO Author Reflections: Treatment Choice for Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 6, p. 3906, doi. 10.1245/s10434-024-15088-0
- By:
- Publication type:
- Article
Validation study on the 2 mm diameter cutoff in lymph node‐positive cases following radical prostatectomy in accordance with the AJCC/UICC TNM 8th edition: Real‐world data analysis from a Japanese cohort.
- Published in:
- International Journal of Urology, 2024, v. 31, n. 6, p. 662, doi. 10.1111/iju.15434
- By:
- Publication type:
- Article
GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone‐sensitive prostate cancer; KYUCOG‐1401.
- Published in:
- International Journal of Urology, 2024, v. 31, n. 4, p. 362, doi. 10.1111/iju.15371
- By:
- Publication type:
- Article
Validation of schedules for optimal prostate‐specific antigen monitoring after radical prostatectomy.
- Published in:
- International Journal of Urology, 2024, v. 31, n. 4, p. 404, doi. 10.1111/iju.15379
- By:
- Publication type:
- Article
Clinical features and oncological outcomes of bladder cancer microsatellite instability.
- Published in:
- International Journal of Urology, 2024, v. 31, n. 4, p. 438, doi. 10.1111/iju.15370
- By:
- Publication type:
- Article
Field experiment of a telesurgery system using a surgical robot with haptic feedback.
- Published in:
- Surgery Today, 2024, v. 54, n. 4, p. 375, doi. 10.1007/s00595-023-02732-7
- By:
- Publication type:
- Article
Novel mechanism of androgen receptor regulation through switching by long non‐coding RNA LINC01126.
- Published in:
- Clinical & Translational Discovery, 2024, v. 4, n. 1, p. 1, doi. 10.1002/ctd2.264
- By:
- Publication type:
- Article
Salvage robot‐assisted radical prostatectomy after carbon ion radiotherapy to the prostate.
- Published in:
- Asian Journal of Endoscopic Surgery, 2024, v. 17, n. 1, p. 1, doi. 10.1111/ases.13279
- By:
- Publication type:
- Article
Differential cancer‐specific survival with curative radiotherapy to the prostate for metastatic prostate cancer according to estimated survival by risk group.
- Published in:
- International Journal of Urology, 2023, v. 30, n. 12, p. 1197, doi. 10.1111/iju.15273
- By:
- Publication type:
- Article
Bone‐modifying agents are protective for symptomatic skeletal events in Radium‐223 treatment.
- Published in:
- International Journal of Urology, 2023, v. 30, n. 11, p. 1029, doi. 10.1111/iju.15259
- By:
- Publication type:
- Article
Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP‐RCC study.
- Published in:
- International Journal of Urology, 2023, v. 30, n. 9, p. 788, doi. 10.1111/iju.15265
- By:
- Publication type:
- Article
Telesurgery and telesurgical support using a double-surgeon cockpit system allowing manipulation from two locations.
- Published in:
- Surgical Endoscopy & Other Interventional Techniques, 2023, v. 37, n. 8, p. 6071, doi. 10.1007/s00464-023-10061-6
- By:
- Publication type:
- Article
Fusion‐targeted biopsy significantly improves prostate cancer detection in biopsy‐naïve men.
- Published in:
- International Journal of Urology, 2023, v. 30, n. 7, p. 600, doi. 10.1111/iju.15188
- By:
- Publication type:
- Article
Effect of genetic polymorphisms on outcomes following nivolumab for advanced renal cell carcinoma in the SNiP-RCC trial.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1903, doi. 10.1007/s00262-023-03367-w
- By:
- Publication type:
- Article
Genetic variations predicting progression with docetaxel and novel androgen‐receptor pathway inhibitors.
- Published in:
- Cancer Science, 2023, v. 114, n. 4, p. 1625, doi. 10.1111/cas.15718
- By:
- Publication type:
- Article
Correlation between extended pelvic lymph node dissection and urinary incontinence at early phase after robot‐assisted radical prostatectomy.
- Published in:
- International Journal of Urology, 2023, v. 30, n. 4, p. 340, doi. 10.1111/iju.15119
- By:
- Publication type:
- Article
A Phase II Trial of Abiraterone With Dutasteride for Second‐Generation Antiandrogen‐ and Chemotherapy‐Naïve Patients With Castration‐Resistant Prostate Cancer.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 4, p. 445, doi. 10.1002/jcph.2191
- By:
- Publication type:
- Article
Comparison of therapeutic features and oncologic outcome in patients with pN1 prostate cancer among robot-assisted, laparoscopic, or open radical prostatectomy.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 2, p. 306, doi. 10.1007/s10147-022-02278-7
- By:
- Publication type:
- Article
Effectiveness and safety of radium‐223 dichloride in patients with castration‐resistant prostate cancer and bone metastases in real‐world practice: A multi‐institutional study.
- Published in:
- International Journal of Urology, 2023, v. 30, n. 2, p. 139, doi. 10.1111/iju.15078
- By:
- Publication type:
- Article
Conceptual assessment of HRQOL among Japanese non‐metastatic castration‐resistant prostate cancer (nmCRPC) patients.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 2, p. 1762, doi. 10.1002/cam4.4955
- By:
- Publication type:
- Article
Impact of trough abiraterone level on adverse events in patients with prostate cancer treated with abiraterone acetate.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 1, p. 89, doi. 10.1007/s00228-022-03420-0
- By:
- Publication type:
- Article
Novel nomogram to predict biochemical recurrence-free survival after radical prostatectomy.
- Published in:
- World Journal of Urology, 2023, v. 41, n. 1, p. 43, doi. 10.1007/s00345-022-04245-3
- By:
- Publication type:
- Article
IMAGENE trial: multicenter, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy of niraparib with PD-1 inhibitor in solid cancer patients with homologous recombination repair genes mutation.
- Published in:
- BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10398-6
- By:
- Publication type:
- Article
Prognostic significance of pathogenic variants in BRCA1, BRCA2, ATM and PALB2 genes in men undergoing hormonal therapy for advanced prostate cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Antiandrogenic Effects of a Polyphenol in Carex kobomugi through Inhibition of Androgen Synthetic Pathway and Downregulation of Androgen Receptor in Prostate Cancer Cell Lines.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 14356, doi. 10.3390/ijms232214356
- By:
- Publication type:
- Article
Cancer‐specific and net overall survival in older patients with de novo metastatic prostate cancer initially treated with androgen deprivation therapy.
- Published in:
- International Journal of Urology, 2022, v. 29, n. 10, p. 1147, doi. 10.1111/iju.14938
- By:
- Publication type:
- Article
Testosterone level in seminal vesicle fluid is a better indicator of erectile function than serum testosterone in patients with prostate cancer.
- Published in:
- International Journal of Urology, 2022, v. 29, n. 10, p. 1155, doi. 10.1111/iju.14953
- By:
- Publication type:
- Article
Extracellular vesicles expressing CEACAM proteins in the urine of bladder cancer patients.
- Published in:
- Cancer Science, 2022, v. 113, n. 9, p. 3120, doi. 10.1111/cas.15438
- By:
- Publication type:
- Article
Active Surveillance in Intermediate-Risk Prostate Cancer: A Review of the Current Data.
- Published in:
- Cancers, 2022, v. 14, n. 17, p. 4161, doi. 10.3390/cancers14174161
- By:
- Publication type:
- Article
Role of Olaparib in the Management of Metastatic Castration-Resistant Prostate Cancer: A Japanese Clinician's Perspective.
- Published in:
- Cancer Management & Research, 2022, v. 14, p. 2389, doi. 10.2147/CMAR.S326114
- By:
- Publication type:
- Article
Impact of nerve sparing in robot‐assisted radical prostatectomy on the risk of positive surgical margin and biochemical recurrence.
- Published in:
- International Journal of Urology, 2022, v. 29, n. 8, p. 824, doi. 10.1111/iju.14900
- By:
- Publication type:
- Article
Radiotherapy plus androgen deprivation therapy for prostate‐specific antigen persistence in lymph node–positive prostate cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 7, p. 2386, doi. 10.1111/cas.15383
- By:
- Publication type:
- Article
Current Status and Future Perspective on the Management of Lymph Node-Positive Prostate Cancer after Radical Prostatectomy.
- Published in:
- Cancers, 2022, v. 14, n. 11, p. 2696, doi. 10.3390/cancers14112696
- By:
- Publication type:
- Article
Narrative review of local prostate and metastasis-directed radiotherapy in the treatment of metastatic prostate cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 6, p. 633, doi. 10.1093/jjco/hyac035
- By:
- Publication type:
- Article
Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabine.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-12528-3
- By:
- Publication type:
- Article
An oral first‐in‐class small molecule RSK inhibitor suppresses AR variants and tumor growth in prostate cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1731, doi. 10.1111/cas.15280
- By:
- Publication type:
- Article
Efficacy of combined androgen blockade therapy in patients with metastatic hormone‐sensitive prostate cancer stratified by tumor burden.
- Published in:
- International Journal of Urology, 2022, v. 29, n. 5, p. 398, doi. 10.1111/iju.14793
- By:
- Publication type:
- Article
Validation of models predicting lymph node involvement probability in patients with prostate cancer.
- Published in:
- International Journal of Urology, 2022, v. 29, n. 5, p. 428, doi. 10.1111/iju.14802
- By:
- Publication type:
- Article
Effect of HLA genotype on intravesical recurrence after bacillus Calmette–Guérin therapy for non-muscle-invasive bladder cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 727, doi. 10.1007/s00262-021-03032-0
- By:
- Publication type:
- Article
Clinical impact of HSD3B1 polymorphism by metastatic volume and somatic HSD3B1 alterations in advanced prostate cancer.
- Published in:
- Andrologia, 2022, v. 54, n. 1, p. 1, doi. 10.1111/and.14307
- By:
- Publication type:
- Article
Predictive factors of survival outcomes in first‐line therapy for metastatic castration‐resistant prostate cancer.
- Published in:
- International Journal of Urology, 2022, v. 29, n. 1, p. 26, doi. 10.1111/iju.14702
- By:
- Publication type:
- Article
Editorial Comment to Endoscopic laser treatment for urine leakage caused by an isolated calyx after robot‐assisted partial nephrectomy.
- Published in:
- IJU Case Reports, 2021, v. 4, n. 6, p. 346, doi. 10.1002/iju5.12349
- By:
- Publication type:
- Article
Unrecognized Pitfall When Doing Nerve-Sparing Surgery in Radical Prostatectomy.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Novel metastatic burden‐stratified risk model in de novo metastatic hormone‐sensitive prostate cancer.
- Published in:
- Cancer Science, 2021, v. 112, n. 9, p. 3616, doi. 10.1111/cas.15038
- By:
- Publication type:
- Article
Dynamics of conditional survival and risk factors in androgen deprivation therapy for prostate cancer using a multi‐institutional Japan‐wide database.
- Published in:
- International Journal of Urology, 2021, v. 28, n. 9, p. 927, doi. 10.1111/iju.14605
- By:
- Publication type:
- Article
Overexpression of claspin promotes docetaxel resistance and is associated with prostate-specific antigen recurrence in prostate cancer.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 16, p. 5574, doi. 10.1002/cam4.4113
- By:
- Publication type:
- Article
HOXB5 Overexpression Is Associated with Neuroendocrine Differentiation and Poor Prognosis in Prostate Cancer.
- Published in:
- Biomedicines, 2021, v. 9, n. 8, p. 893, doi. 10.3390/biomedicines9080893
- By:
- Publication type:
- Article